Startup Basics

A spec is not a school essay. It is not a product page. It is not a “nice to have” doc you throw together after the code works. A patent spec is a survival document. It must survive hard questions from patent examiners in the U.S., Europe, China, India, and more. It must survive later […]

Semiconductor and Chip IP: Global Filing Playbook If you build chips, you already know the truth: your real product is not only silicon. It is also the ideas inside it. The layout tricks. The timing fixes. The way your firmware talks to your hardware. The method that makes your power drop by 18% without hurting

Clean tech is moving fast. If you build in batteries, grid software, carbon capture, EV parts, solar, hydrogen, or new materials, you are not just building a product. You are building a “how.” And in clean tech, the “how” gets copied the moment it works. That is why patents matter. Not as a trophy. As

Medical Devices: Global Filing Strategy and Regulatory Timing You can have the best medical device in the world, and still lose the market if you file late, file in the wrong places, or file in a way that gets boxed in by your own regulatory steps. Patents and regulatory work do not live in separate

Biotech patents can feel like a different planet when you are at seed stage. You are building science, hiring your first real team, trying to get clean data, and still figuring out what your product will be. Then someone says, “We need patents worldwide,” and it sounds expensive, slow, and full of legal traps. Here

Robots are no longer “future tech.” They are here, in warehouses, labs, farms, hospitals, and factories. And when robotics teams build something that works, the next question is not just “Can we ship it?” It is “Can someone copy it?” That is what patents are for. But robotics patents are tricky in a way that

Software patents feel simple on paper: you built something new in code, so you want to protect it. Then you look across borders and realize the rules do not “travel” the way your software does. In one country, a claim that reads like “a method for recommending items to a user” might be dead on

AI is moving faster than patent law. That gap is where most founders get stuck. If you are building AI for robotics, healthcare, security, finance, or industrial systems, your edge is often in the logic: how your model learns, how it makes a decision, how it adapts in the real world, and how it connects

Most founders hear the words “prior art search” and think: legal pain, slow timelines, and a bill they do not want. But a global prior art search is not a “lawyer thing.” It is a founder tool. If you treat it like a product decision—clear goal, clear scope, fast learning loops—it becomes one of the

Most founders do not lose because their tech is weak. They lose because they ship into a market they cannot legally sell into. That is what “freedom to operate” (FTO) is about. It is the simple question: Can we make, use, sell, and ship this product in this country without stepping on someone else’s patent?